How To Value Hpl In India



Similar documents
HCC BUY. Infrastructure January 29, 2016

Just Dial Ltd Bloomberg Code: JUST IN

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, CRISIL Ltd. Recommendation (Rs.)

Gujarat State Petronet Ltd. INR 135

Company Overview. Financial Performance

GAIL (India) Ltd. INR 346

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

Quant Picks United Breweries

Flexituff International Ltd. (FIL)

Tube Investments of India Ltd Bloomberg Code: TI IN

Khambatta Securities Ltd.

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Maruti Suzuki. Source: Company Data; PL Research

Navin Fluorine International

GlaxoSmithKline Consumer Healthcare

Mangalam Cement Weak volumes marred performance

Minda Industries Ltd. INR 886

Britannia Industries

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Strong operational performance

Simplex Infrastructures

Tree House Education & Accessories

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP Target Price JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

Techno Electric & Engineering Limited

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

RamKrishna Forgings Ltd.

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Kotak Mahindra Bank Rs 685

Jubilant Life Sciences

BUY RSWM LTD SYNOPSIS. CMP Target Price SEPTEMBER 1 st Result Update(PARENT BASIS): Q1 FY16

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP Target Price SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

Pidilite Industries. Source: Company Data; PL Research

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Va Tech Wabag. Source: Company Data; PL Research

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Bata India Ltd. (BIL)

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

Aurobindo Pharma. Source: Company Data; PL Research

Butterfly Gandhimathi (GANAP) 188

Granules India Ltd. INR 113

Smruthi Organics Limited BSE Scrip Code:

Research Analysts. September 30, 2015

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

UltraTech Cement Ltd.

Gladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months

Results impacted by subdued demand

Research Analysts. June 30, Lupin LUPIN Buy in the range of

Larsen & Toubro. Source: Company Data; PL Research

Cipla Ltd. Rs India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

Research Analysts. Granules GRANUL Buy in the range of EID Parry EIDPAR Buy in the range of

JLR Nov-15 wholesale up 24% YoY to 51,021 units

Share gains with healthy margin uptick; Retain Buy

Outlook and valuation

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

Axis Bank. Strong core performance. Source: Company Data; PL Research

India Equity Research Telecommunications September 2, 2015 Management Meet Update

Sadbhav Engineering. Weak execution, but strong order outlook. Source: Company Data; PL Research

Sphere Global Services Limited

Dr. Reddy's Laboratories

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015

CMP: JUNE 2016 SWARAJ ENGINES LTD

Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage

Higher other income drive the quarter

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

BUY. JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP Target Price DECEMBER 29 th 2015.

Bharat Earth Movers (BEML)

S.H.Kelkar &Co. Ltd. Buy. Proxy FMCG Play. Outlook & Valuation. November 16, 2015

Bharti Infratel (BHAINF) 370

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

Private drilling fluid technology service leader

Bright Smart (1428 HK)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

How To Understand And Value Gsk Pharma

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

Tata Motors Ltd. Buy. New launches at domestic business as well as JLR to drive growth. February 12, 2016

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Investment Rationale

State Bank of India. Source: Company Data; PL Research

Reliance Communication

East India Hotels (EIH) Ltd Growing Strategically

Welspun India Ltd Bloomberg Code: WLSI IN

CD Equisearch Pvt Ltd

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

Research Analysts. April 8, West Coast Paper Mills WESCOA Buy in the range of

Sep 2015: Strongest ever dispatch growth of 15% YoY

Mahindra CIE Automotive Ltd.

Transcription:

Materials - Containers & Packaging Oct 01, 2015 Bloomberg Code: HPPL IN India Research - Stock Broking Backed by Acquisition, Set to Augment Market Share New acquisition: In FY15, HPPL acquired 100% of Positive Packaging Industries Limited, India (PPIL). PPIL is well established in this packaging market with better technology, well established infrastructure and good customer base. Entry into new markets and synergy benefits are expected to push the growth of the company. Strong market share in fragmented flexible packaging segment: HPPL is leader in consumer packaging. It is among the top three flexible packaging companies in India serving various large and mid corporate players in the FMCG business. Most of the product line manufactured by the company goes largely in the consumer goods industry. It provides services to over 50 customers worldwide. Growth in consumer goods: As most of the products of HPPL go into consumer products, any revival in the growth of the segments like FMCG and expected positive growth from other sectors such as Healthcare, E-Commerce are expected to drive the growth of the company. Strong parent: With revenue of Rs 200-210 Bn, its parent company Finland based Huhtamaki Oyj is one of the top 10 consumer packaging companies in the world. It is amongst the top market leaders with good market share in Europe & US. Valuation and Outlook With sizable market position in the domestic flexible packaging products, HPPL established well with good growth in topline and bottomline in the domestic flexible packaging with zero debt on books (prior to acquisition). To further strengthen its presence in the established markets, HPPL acquired PPIL. This acquisition led to sharp drop in RoE% and RoCE% as the synergy benefits and operating leverage could take time to unfold: and are expected to increase post 2017. At CMP of Rs.273, the stock is currently trading at PE of 18.7x on CY17E EPS. Considering the strong MNC parent, proven performance of the HPPL, new acquisition which is leading to consolidation and the expected synergy benefits, we initiate coverage and assign PE of 22.0x on CY17E EPS with a BUY rating for target price Rs.322, representing an upside potential of 18% for the company in the long term. Key Risks 1) Raw material prices. 2) Highly competitive sector. Recommendation (Rs.) BUY CMP (as on Sep, 30, 2015) 273 Target Price 322 Upside (%) 18 Stock Information Mkt Cap (Rs.mn/US$ mn) 19847 / 301 52-wk High/Low (Rs.) 334 / 167 3M Avg. daily volume (mn) 0.1 Beta (x) 0.8 Sensex/Nifty 25981 / 7905 O/S Shares(mn) 72.7 Face Value (Rs.) 2.0 Shareholding Pattern (%) Promoters 68.8 FIIs 1.2 DIIs 5.5 Others 24.5 Stock Performance (%) 1M 3M 6M 12M Absolute (3) 15 17 42 Relative to Sensex (2) 23 26 45 Source: Bloomberg Relative Performance* 180 155 130 105 80 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 HPPL IN Source: Bloomberg; *Index 100 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sensex Sep-15 Exhibit 1: Valuation Summary (Rs. Mn) YE Dec (Rs. Mn) CY13 CY14 CY15E CY16E CY17E Net Sales 11573 13114 21300 23750 26260 EBITDA 1145 1177 2026 2426 2875 EBITDA Margin (%) 9.9 8.9 9.5 10.2 10.9 Adj. Net Profit 549 647 447 758 1061 EPS (Rs.) 8.8 8.9 6.1 10.4 14.6 RoE (%) 14.7 13.5 7.7 12.2 15.2 PE (x) 8.5 20.3 44.4 26.2 18.7, *Represents multiples for CY13 & CY14 are based on historic market price For private circulation only. For important information about Karvy s rating system and other disclosures refer to the end of this material. Karvy Stock Broking Research is also available on Bloomberg, KRVY<GO>, Thomson Publishers & Reuters Analyst Contact Jagannadham Thunuguntla 040-3321 6296 jagannadham.t@karvy.com 1

Company Financial Snapshot (Y/E Mar) Profit & Loss (Rs. Mn) CY15E CY16E CY17E Net sales 21300 23750 26260 Optg. Exp (Adj for OI) 19324 21294 23404 EBITDA 2026 2426 2875 Depreciation 910 920 900 Interest 499 510 522 Other Income 80 80 90 PBT 697 1076 1543 Tax 230 289 463 Adj. PAT 447 758 1061 Profit & Loss Ratios EBITDA margin (%) 9.5 10.2 10.9 Net Profit margin (%) 2.1 3.2 4.0 P/E (x) 44.4 26.2 18.7 EV/EBITDA (x) 12.1 10.0 8.2 Dividend yield (%) 0.7 0.7 0.8 Balance sheet (Rs. Mn) CY15E CY16E CY17E Total Assets 17424 18650 19639 Net Fixed assets 7971 7551 7301 Current assets 3926 5588 8557 Other assets 288 413 860 Total Liabilities 17424 18650 19639 Networth 5947 6531 7393 Debt 6000 6010 5500 Current Liabilities 4610 5201 5812 Deferred Tax 98 106 116 Balance Sheet Ratios RoE (%) 7.7 12.2 15.2 RoCE (%) 11.6 11.5 14.5 Net Debt/Equity 0.8 0.7 0.5 Equity/Total Assets 0.3 0.4 0.4 P/BV (x) 3.3 3.0 2.7 Exhibit 2: Shareholding Pattern (%) Company Background With 68.8% ownership of The Paper Products with Finland based Huhtamaki Oyj, the company is renamed as Huhtamaki Paper Products Ltd in May 2014. HPPL is a pioneer in technology and market leader in flexible packaging in India. HPPL produces a wide range of custom designed film, foil and paper based laminate structures for primary packaging of products in solid, powder or liquid form, in consumer pack sizes. It also offers a range of labeling options. It has 4 plants at Thane, Silvassa, Hyderabad & Rudrapur which have got certified from various global agencies. Silvassa and Hyderabad plants also hold US DMF (Drug Master Files) certification, required by pharmaceutical customers. Its major subsidiary Webtech Labels is specialized in manufacturing high-end pressure sensitive labels, especially to pharmaceutical customers. HPPL has international business division across 4 continents and over 50 customers. It also manufactures lined cartons and systems for primary packaging of powders and solids. solids. In FY15, HPPL acquired 100% of Positive Packaging Industries Ltd, India (PPIL). Cash Flow (Rs. Mn) CY15E CY16E CY17E PBT 697 1076 1543 Depreciation 910 920 900 Interest (net) 499 510 522 Tax (230) (289) (463) Changes in WC (1614) (841) (335) CF from Operations 564 1240 2081 Capex (6069) (500) (670) Investment 509 0 0 CF from Investing (5480) (420) (580) Change in Equity 0 0 0 Change in Debt 5581 10 (510) Dividends (244) (175) (175) CF from Financing 4838 (675) (1207) Change in Cash (79) 145 294 Exhibit 3: Geographical Revenue Segmentation (Rs. Mn) DIIs 5.5% FIIs 1.2% Others 24.5% Promoters 68.8% 9000 6000 3000 0 8830 8617 9878 1688 2131 2265 CY12 CY13 CY14 Domestic Export Source: BSE, Karvy Research 2

New acquisition to drive the growth: Oct 01, 2015 PPIL is a highly respected and quality manufacturer of flexible packaging products. It is well established in flexible packaging market with better technology, robust infrastructure and good customer base, operating through six manufacturing plants in India around Mumbai and Bengaluru. Both HPPL and Positive Packaging Products are into Primary packaging i.e. the packaging in which products are filled and are in direct contact. Positive Packaging has strong hold in African markets and exports which hover around 40% of total sales. Hutamaki PPL will also start exporting some of its products to African markets, wherein it was not present earlier. Huhtamaki, through this acquisition of PPIL, is basically looking to increase is presence in the various emerging markets. This, along with synergy benefits, could help both the companies to further strengthen market position in domestic and international markets. HPPL took a substantial expansion in 2014 with capex close to Rs.700 to Rs.750 Mn. Sizable market share in fragmented flexible packaging segment: HPPL is leader in consumer packaging. It is among the top three flexible packaging companies in India serving various large and mid corporate players in FMCG sector. Most of the product line manufactured by the company is largely consumed in the consumer goods industry. It provides service to over 50 customers worldwide, with around 20% of revenue from exports. The flexible packaging business in India is highly fragmented in nature. There are numerous smaller players with revenue less than Rs 5000 Mn. As much as around 50% of the market is still in unorganized space. Expected revival in growth in consumer goods sector: With diverse products, most of them go into consumer products. Any revival in the growth of the segments like FMCG and expected positive growth from other sectors such as Healthcare and E-Commerce are expected to drive the growth of the company. Pressure Sensitive Labels, Specialised Pouches, Shrink Sleeves, Wet Strength Labels and Specialized Cartons are few of its products. The company s future course is dependent on the health and buying behavior of the big players in the FMCG and Healthcare sectors. Fast increasing array of packaged foods & consumption products, growth in innumerable brands and the long term positive outlook on FMCG goods are expected to drive the demand for flexible packaging products. Considering the demand from packaging dependent main sectors such as FMCG, Healthcare and E-commerce, flexible packaging industry is expected to grow around 12% to 14%. HPPL deals with the large and mid corporate who are more into organized retail like HUL, etc. Strong Parent Company: With revenue of Rs.200 to Rs.210 Bn, its parent company Huhtamaki Oyj is one of the top 10 consumer packaging companies in the world. It is among the top market leaders with strong market share in Europe and US. Its main businesses are: Flexible Packaging Films, Food Service and Molded Fibre. Kraft, Costco, Nestle, McDonald s and Unilever are its major customers. It is present in Europe, US and emerging markets. Focus on NASP Programme: Its innovation program called NASP (New Applications, Structures and Products/Processes) which focuses more on adding value to the brands packaged at cost efficiencies. Its main objectives are to create new business through finding new applications & markets and to introduce new packaging products and structures. It protects or even improves existing business share from customers by creating improved packaging solutions, or improving cost competitiveness. It successfully delivered various innovative products in tea, coffee, shampoo, confectionery and pickle. During 2014, the NASP sales were around 29% of total sales. With more focus on delivering innovative products at very effective cost points will help to increase the penetration of customer products, the growth in these segments likely to continue. 3

Exhibit 4: Business Assumptions Y/E Dec (Rs. Mn) CY14 CY15E CY16E CY17E Comments Consolidated Revenue 13114 21300 23750 26260 Revenue Growth (%) 13.3 62.4 11.5 10.6 EBITDA 1177 2026 2426 2875 EBITDA Margins (%) 8.9 9.5 10.2 10.9 PAT (normalized) 647 447 758 1061 PAT Growth (%) 18.0 (30.9) 69.6 39.9 Fully Diluted EPS (Rs) 8.9 6.1 10.4 14.6 Fully Diluted EPS Growth (%) 1.7 (30.9) 69.6 39.9 The revenue from PPIL is going to drive the growth in CY15E and CY16E. Significant jump in CY15 is because of PPIL s acquisition. EBITDA Margins (%) are expected to be maintained as lower crude oil prices are expected to be low. Interest costs for the new acquisition are affecting the bottomline. Capex (ex. Acquisition) - cash capex (806) (6069) (500) (670) High capex in CY15 is due to acquisition. Net CFO 938 564 1240 2081 Net Debt (1561) 4609 4473 3638 Free Cash Flow 132 (5506) 740 1411 Good growth in last few years Exhibit 5: 30000 20000 10000 0 4.7% 4.9% 4.0% 6% 3.2% 4% 2.1% 2% 0% CY13 CY14 CY15E CY16E CY17E Sales (Rs. Mn) Net Profit (%) 11573 13114 21300 23750 26260 With CAGR of 8% in sales in the last three years, the company generated revenue of Rs 13114 Mn in CY14. Mainline flexibles and Labeling materials, which form the bulk of consumer packaging business, had a sales revenue growth of 13.3%. The small specialized cartons business had a negative growth of 5%, primarily due to lower off-take from seeds customers. The company s exports in 2014 grew by 5.7% to Rs 2223 mn over 2013. Stable Operating profit margins Exhibit 6: 3000 10.2% 10.9% 11.0% 2000 1000 0 9.9% 9.5% 10.4% 9.8% 8.9% 9.2% 8.6% 8.0% CY13 CY14 CY15E CY16E CY17E EBITDA (Rs Mn) EBITDA Margin (%) 1145 1177 2026 2426 2875 Over the years, the company is maintaining the operating profit margins around 8-10%. In CY14, the operating profit margins declined in few specialized segments with volatile crude oil prices showing negative trend. In the long run, management is looking for EBITDA margins between 9% to 11%. 4

On Debt and Capex Exhibit 7: 6000 4000 2000 462 382 419 806 6000 6069 6010 500 5500 670 0 CY13 CY14 CY15E CY16E CY17E Borrowings (Rs Mn) Capex & Acquisitions (Rs. Mn) Prior to acquisition, HPPL is zero debt company with normal capex of around Rs 300-400 Mn. Post the acquisition, the debt on the books has increased significantly as most of the debt is funded through loan raised from its parent company and debt of newly acquired company. The company has done sizable capex around Rs 600 Mn in CY14. The normal capex is around Rs 400-500 Mn. Return Ratios (%) Exhibit 8: 20 15 10 5 16.8 14.7 14.2 11.6 11.5 13.5 14.5 15.2 7.7 12.2 CY13 CY14 CY15E CY16E CY17E RoE% RoCE% RoE% is expected to decrease in CY15E because of high interest costs on debt raised for inorganic growth. It is expected to decrease from 13.5% in CY14 to 7.7% in CY15E but expected to improve in CY17E on the back of expected growth in topline and improvement in operating profit margins. The RoCE% is also expected to decrease in CY15E because of the new acquisition which has cumulative debt of around Rs 2500 mn but is expected to improve from 11.6% in CY15E to 15.2 in CY17E. Others In order to part fund the acquisition of PPIL, HPPL has allotted 10.02 mn equity shares of FV of Rs. 2 each to Huhtamaki group in Aug 2014. This has increased HPPL s equity capital from Rs. 125.4 mn as on June 30, 2014 to Rs. 145.4 mn. Acquisition: On 8th July, 2014, the company and the shareholders of Positive Packaging Industries Limited, India, ( Positive ) had entered into a definitive agreement, pursuant to which the company on 30th January, 2015, acquired 100% of outstanding shares of Positive. This has been completed, after obtaining all necessary approvals. The total enterprise value was Rs. 7936.6 Mn inclusive of debt and debt like items of Rs 2875.4 Mn, subject to closing adjustments. The net amount paid by the company towards the acquisition is Rs 5061.2 Mn. In addition, the company has incurred expenses towards acquisition amounting to Rs.49.2 Mn, out of which Rs 31.5 Mn has been debited to investment account. 5

Exhibit 9: Company Snapshot (Ratings) Low High 1 2 3 4 5 Quality of Earnings 33 Domestic Sales 33 Exports 33 Net Debt/Equity 33 Working Capital Requirement 33 Quality of Management 33 Depth of Management 33 Promoter 33 Corporate Governance 33 6

Valuation & Outlook With sizable market position in the domestic flexible packaging products, HPPL established well with good growth in topline and bottomline in the domestic flexible packaging with zero debt on books (prior to acquisition). To further strengthen its presence in the established markets, HPPL acquired PPL. With this acquisition, the debt on the books raised to around Rs 5500 Mn and is among the top 2 players in Flexible packaging industry. This acquisition led to sharp drop in RoE% and RoCE% as the synergy benefits and operating leverage could take time and are expected to increase post 2017. Consolidation of the top players supported by strong parent backup and strong operating cash flow are expected to augur well for the company in the long term. At CMP of Rs.273, the stock is currently trading at PE of 18.7x on CY17E EPS. Considering the strong Multi National Company (MNC) parent, proven performance of the HPPL, new acquisition which is leading to consolidation and the expected synergy benefits, we initiate coverage and assign PE of 22.0x on CY17E EPS a with a BUY rating for target price Rs.322, representing an upside potential of 18% for the company in the long term. Exhibit 10 (a): Comparative Valuation Summary CMP (Rs.) Mcap EV/EBITDA (x) P/E (x) EPS (Rs.) (Rs. Mn) CY15 CY16E CY17E CY15 CY16E CY17E CY15 CY16E CY17E HPPL** 273 19847 12.1 10.0 8.2 44.4 26.2 18.7 6.1 10.4 14.6 Uflex * 157 11359 4.2 3.6 3.3 4.5 3.9 3.4 35.3 40.4 45.9 Source: Bloomberg, Karvy Research, *Uflex Financial Year Ending is March 31st. **HPPL CY15 numbers are estimates. Exhibit 10 (b): Comparative Operational Metrics Summary CAGR % (FY15-17E) RoE (%) Price Perf (%) Net Sales (Rs. Mn) Sales EBITDA EPS CY15 CY16E CY17E 3m 6m 12m CY15 CY16E CY17E HPPL** 11.0 19.1 54.0 7.7 12.2 15.2 15.2 17.4 42.1 21300 23750 26260 Uflex * 14.1 12.3 14.1 8.7 8.8 9.0 29.5 33.9 6.1 25480 29200 33170 Source: Bloomberg, Karvy Research, *Uflex Financial Year Ending is March 31st, **HPPL CY15 numbers are estimates. Key Risks yvolatile Raw material prices: Based on the petro-chemicals outlook, there is a risk of high volatility. High volatality in raw material costs could put pressure on the gross and operating profit margins. yhighly competitive sector: The sector is highly competitive sector with many unorganised players. 7

Financials Exhibit 11: Income Statement YE Dec (Rs. Mn) CY13 CY14 CY15E CY16E CY17E Revenues 13114 21300 23750 26260 26260 Growth (%) 13.3 62.4 11.5 10.6 10.6 Operating Expenses 11990 19324 21294 23404 23404 EBITDA 1177 2026 2426 2875 2875 Growth (%) 2.8 72.2 19.7 18.5 18.5 Depreciation & Amortization 439 910 920 900 900 Other Income 69 80 80 90 90 EBIT 896 1196 1586 2065 2065 Interest Expenses 39 499 510 522 522 PBT 857 697 1076 1543 1543 Tax 191 230 289 463 463 Adjusted PAT 647 447 758 1061 1061 Growth (%) 18.0 (30.9) 69.6 39.9 39.9 Exhibit 12: Balance Sheet YE Dec (Rs. Mn) CY13 CY14 CY15E CY16E CY17E Cash 158 117 38 183 508 Sundry Debtors 2285 2473 4371 5387 6019 Inventory 935 983 2374 2787 3041 Loans & Advances 288 413 860 910 930 Investments 548 1863 1354 1354 1354 Net Block 2318 2753 7971 7551 7301 CWIP 110 59 0 0 0 Total Assets 6680 8850 17424 18650 19639 Current Liabilities & Provisions 2061 2418 4610 5201 5812 Debt 462 419 6000 6010 5500 Deferred Tax liability 48 91 98 106 116 Total Liabilities 2571 2928 10708 11317 11428 Shareholders Equity 125 145 145 145 145 Reserves & Surplus 3783 5530 5802 6385 7247 Total Networth 3908 5675 5947 6531 7393 Minority Interest 201 220 233 254 284 Total Networth & Liabilities 6680 8850 17424 18650 19639 8

Exhibit 13: Cash Flow Statement YE Dec (Rs. Mn) CY13 CY14 CY15E CY16E CY17E PBT 807 813 697 1076 1543 Depreciation 420 439 910 920 900 Interest 37 31 499 510 522 Tax Paid (250) (150) (230) (289) (463) Inc/dec in Net WC (339) (160) (1614) (841) (335) Other Income (35) (67) (80) (80) (90) Cash flow from operating activities 509 938 564 1240 2081 Inc/dec in capital expenditure (382) (806) (6069) (500) (670) Inc/dec in investments 56 (1315) 509 0 0 Cash flow from investing activities (216) (2043) (5480) (420) (580) Inc/dec in borrowings (47) (29) 5581 10 (510) Issuance of equity 0 1342 0 0 0 Dividend paid (190) (205) (244) (175) (175) Interest paid (38) (31) (499) (510) (522) Cash flow from financing activities (285) 1064 4838 (675) (1207) Net change in cash 9 (41) (79) 145 294 Exhibit 14: Key Ratios YE Dec CY13 CY14 CY15E CY16E CY17E EBITDA Margin (%) 9.9 8.9 9.5 10.2 10.9 EBIT Margin (%) 32.8 4.2 33.5 32.6 30.2 Net Profit Margin (%) 4.7 4.9 2.1 3.2 4.0 Dividend Payout ratio 32.0 31.4 32.5 19.2 15.6 Net Debt/Equity (0.1) (0.3) 0.8 0.7 0.5 RoE (%) 14.7 13.5 7.7 12.2 15.2 RoCE (%) 16.8 14.2 11.6 11.5 14.5 Exhibit 15: Valuation Parameters YE Dec CY13 CY14 CY15E CY16E CY17E EPS (Rs.) 8.8 8.9 6.1 10.4 14.6 DPS (Rs.) 2.8 2.8 2.0 2.0 2.3 BV (Rs.) 62.3 78.0 81.8 89.8 101.7 PE (x) 8.5 20.3 44.4 26.2 18.7 P/BV (x) 1.2 2.3 3.3 3.0 2.7 EV/EBITDA (x) 3.9 9.8 12.1 10.0 8.2 EV/Sales (x) 0.4 0.9 1.1 1.0 0.9 ; *Represents multiples for CY13 & CY14 are based on historic market price 9

Stock Ratings Absolute Returns Buy : > 15% Hold : 5-15% Sell : <5% Connect & Discuss More at 1800 425 8283 (Toll Free) research@karvy.com Live Chat f in You Tube Disclaimer Analyst certification: The following analyst(s), Jagannadham Thunuguntla, who is (are) primarily responsible for this report and whose name(s) is/are mentioned therein, certify (ies) that the views expressed herein accurately reflect his (their) personal view(s) about the subject security (ies) and issuer(s) and that no part of his (their) compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report. Disclaimer: Karvy Stock Broking Limited [KSBL] is a SEBI registered Stock Broker, Depository Participant, Portfolio Manager and also distributes financial products. The subsidiaries and group companies including associates of KSBL provide services as Registrars and Share Transfer Agents, Commodity Broker, Currency and forex broker, merchant banker and underwriter, Investment Advisory services, insurance repository services, financial consultancy and advisory services, realty services, data management, data analytics, market research, solar power, film distribution and production, profiling and related services. Therefore associates of KSBL are likely to have business relations with most of the companies whose securities are traded on the exchange platform. The information and views presented in this report are prepared by Karvy Stock Broking Limited and are subject to change without any notice. This report is based on information obtained from public sources, the respective corporate under coverage and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of KSBL. While we would endeavor to update the information herein on a reasonable basis, KSBL is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent KSBL from doing so. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. KSBL will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. This material is for personal information and we are not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither KSBL nor any associate companies of KSBL accepts any liability arising from the use of information and views mentioned in this report. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Past performance is not necessarily a guide to future performance. Forward-looking statements are not predictions and may be subject to change without notice. Actual results may differ materially from those set forth in projections. y Associates of KSBL might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. y Associates of KSBL might have received compensation from the subject company mentioned in the report during the period preceding twelve months from the date of this report for investment banking or merchant banking or brokerage services from the subject company in the past twelve months or for services rendered as Registrar and Share Transfer Agent, Commodity Broker, Currency and forex broker, merchant banker and underwriter, Investment Advisory services, insurance repository services, consultancy and advisory services, realty services, data processing, profiling and related services or in any other capacity. y KSBL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. y Compensation of KSBL s Research Analyst(s) is not based on any specific merchant banking, investment banking or brokerage service transactions. y KSBL generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. y KSBL or its associates collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. y KSBL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report and have no financial interest in the subject company mentioned in this report. y Accordingly, neither KSBL nor Research Analysts have any material conflict of interest at the time of publication of this report. y It is confirmed that KSBL and Research Analysts, primarily responsible for this report and whose name(s) is/ are mentioned therein of this report have not received any compensation from the subject company mentioned in the report in the preceding twelve months. y It is confirmed that Jagannadham Thunuguntla, Research Analyst did not serve as an officer, director or employee of the companies mentioned in the report. y KSBL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. y Neither the Research Analysts nor KSBL have been engaged in market making activity for the companies mentioned in the report. y We submit that no material disciplinary action has been taken on KSBL by any Regulatory Authority impacting Equity Research Analyst activities. Karvy Stock Broking Limited Plot No.31, 6th Floor, Karvy Millennium Towers, Financial District, Nanakramguda, Hyderabad, 500 032, India Tel: 91-40-2331 2454; Fax: 91-40-2331 1968 For More updates & Stock Research, visit www.karvyonline.com 10